about
Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infectionHemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical PictureTregs in infection and vaccinology: heroes or traitors?Application of IL-2 therapy to target T regulatory cell functionCytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccinesRegulatory T cells: Mechanisms of suppression and impairment in autoimmune liver diseaseHomeostasis and function of regulatory T cells in HIV/SIV infectionRegulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?Modulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancerRegulatory T-cells: diverse phenotypes integral to immune homeostasis and suppressionCell-mediated immunity to human CMV infection: a brief overviewPotential treatment of inflammatory bowel disease: a review of helminths therapyFoxp3+ regulatory T cells are required for recovery from severe sepsisCritical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infectionGammaherpesvirus Co-infection with Malaria Suppresses Anti-parasitic Humoral ImmunityIncreased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infectionTregs control the development of symptomatic West Nile virus infection in humans and miceIPS-1 Is Essential for the Control of West Nile Virus Infection and ImmunityViral Vaccines and CTL ResponseImmune Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationExpansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infectionArsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003-2012Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir hostAdenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance.Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infectionImpact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort studyA role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.Profiling helper T cell subset gene expression in deer mice.Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.Imaging host-pathogen interactions.Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cellsIL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection.Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation.Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells.Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirusAntiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.
P2860
Q26748624-490F9AE5-DF22-48FF-9745-797D23ECCA5CQ26766338-25F6247F-EE52-43C2-A8C0-C1577C0E1B23Q26822874-7C47444F-1216-4B81-8A6C-4E30D514B6B4Q26827327-76BF04A7-F579-499F-8990-E9F17F445F74Q26827712-08A998F7-9782-4EE0-843C-639579431BF3Q26827787-D4832CDD-128E-41C4-B4E2-CB9F43DA3A41Q26995345-CEC49A1E-DDCA-432C-8AE8-9584CC4AAD87Q27001221-03EDAB35-F937-4351-B4DD-EFAF0800644FQ27022761-68A7A4B6-FE31-4B9B-A126-8937BD71A5BDQ27022973-EF49E196-B7D0-43AC-87EA-1C117A339B8AQ27026981-DA2E4BAE-3268-4DB1-91F1-F0BD7AE43A71Q27027621-C7BB7F60-D562-43E7-946D-9DA49E5C7EABQ27317316-20051824-C454-479D-9412-51B69ADB1A4CQ27318086-3DC7EFB0-10C7-41A1-B3EA-E7EE6EBD3C19Q27320062-14A6D95A-7986-4568-9777-AAE6A9A38B08Q27482577-817EC1CE-6FD4-4971-89CF-D4839FB99CDCQ27490259-E846480E-C85E-4460-A74F-16A3194DB36CQ27490889-F54BFB67-B3A7-49EA-B411-66DA05A97B5DQ27491330-ECA4317D-C0CD-4B4C-B031-0B6BF14C10A5Q28072627-2E407B4A-2470-4BF2-A865-B0D335C35675Q28305927-3A3C65A2-B286-4F7B-BA7A-4F9DB3B666CDQ28393717-290629D5-7646-4E28-B801-763D858C412DQ28578953-404B3B26-EBFA-41E4-8436-8CABD55B5093Q29615344-B0E0B734-A027-450A-9B84-9A515F009780Q30362107-A73DE0E7-6282-4BEF-AFAC-244606364E0AQ30402640-7246DED2-7166-4CBA-AF71-4E6571B4F8B9Q30431350-33E118FF-B66C-480C-B5CA-B8FFCF5B7FACQ30479825-2F9C80B8-C20C-49C5-9B86-0772B4F880A0Q33254331-BA9017C8-8808-4503-95B5-A5147B947374Q33265416-A62B947F-704C-4BFB-8245-CB98EF046720Q33319890-A7B736A2-496D-4304-87C2-0BACDA3E1949Q33326987-E0CFB3E6-AB9D-4569-922C-953FC0272EC7Q33327498-7E448E36-74A8-474A-865F-9027BE33F50AQ33356616-1FF57247-337D-40D1-A442-F7881C5EF690Q33432759-46F95049-C76D-45F2-8C7C-E2E2CCDE7A1EQ33497925-2BDBD788-572B-4F3C-9C0F-782E6BFD0C5CQ33501735-09728918-D674-434A-BD12-A5BEB055F431Q33540173-27F62A57-AF7B-4E0D-B299-72874DF3F16DQ33587443-75AE7E3E-3872-4548-88EF-3B1385EFB276Q33640197-407AE1FE-3796-4028-B8E9-80E999D2280B
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Natural regulatory T cells in infectious disease.
@ast
Natural regulatory T cells in infectious disease.
@en
type
label
Natural regulatory T cells in infectious disease.
@ast
Natural regulatory T cells in infectious disease.
@en
prefLabel
Natural regulatory T cells in infectious disease.
@ast
Natural regulatory T cells in infectious disease.
@en
P356
P1433
P1476
Natural regulatory T cells in infectious disease.
@en
P2093
Barry T Rouse
P304
P356
10.1038/NI1181
P407
P577
2005-04-01T00:00:00Z